Platelet-rich plasma and other injectables in the young athlete
- PMID: 40433253
- PMCID: PMC12088118
- DOI: 10.1016/j.jposna.2024.100008
Platelet-rich plasma and other injectables in the young athlete
Erratum in
-
Erratum Regarding Missing Patient Consent Statements in Previously Published Articles.J Pediatr Soc North Am. 2024 Sep 9;8:100102. doi: 10.1016/j.jposna.2024.100102. eCollection 2024 Aug. J Pediatr Soc North Am. 2024. PMID: 40433013 Free PMC article.
Abstract
Pediatric sports participation and subsequent injuries have increased in parallel. Additionally, pediatric athletes and families are highly invested in rapid return to pre-injury status and the ability to sustain high impact loads and tension. Recently, an increase and diversification of biologically derived substances, known as orthobiologics, have been used to accelerate tissue healing. While commonly used in adults, the indications are ambiguous, and evidence for effectiveness is conflicting. Despite this, an interest in pediatric indications for orthobiologics has increased as both a standalone intervention and as a supplement to current treatment. There is a dearth of literature pertaining to the pediatric population, which warrants a review of what research has been performed. The purpose of this review was to critically examine the indications and results of orthobiologics in immature athletes. Much of the existing literature is composed of case studies or studies performed with relatively small sample sizes. As such, we believe more research is needed in almost every context for absolute guidelines and recommendations to be established. While orthobiologics have been purported to provide a significant healing benefit to augment the treatment of sports injuries, we find no additional benefit compared to standard treatment.
Key concepts: 1)While orthobiologics have been used in small sample sizes to provide additional healing for pediatric patients being treated for sports-related injuries, there is little research in large cohorts of pediatric athletes.2)Adding to the ambiguity, the literature that does exist presents conflicting findings regarding benefits of orthobiologics.3)Orthobiologics have the potential to provide significant advanced healing benefits, however significantly more research of larger cohort size, higher evidence level, and a pediatric-only population is necessary for absolute guidelines and recommendations to be made.
Keywords: Mesenchymal stem cells; Orthobiologics; Pediatric sports medicine; Platelet-rich-plasma; Sports medicine.
© 2024 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Theodore Ganley reports a relationship with Arthrex that includes: travel reimbursement. Theodore Ganley has received research support from Allosource and Vericel. He has also received education payments from Paladin Technology Solutions and hospitality and education payments from Arthrex. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- LaPrade R.F., Geeslin A.G., Murray I.R., Musahl V., Zlotnicki J.P., Petrigliano F., et al. Biologic treatments for sports injuries II think tank-current concepts, future research, and barriers to advancement, part 1: biologics overview, ligament injury, tendinopathy. Am J Sports Med. 2016;44(12):3270–3283. doi: 10.1177/0363546516634674. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
